Two-year accelerated corneal cross-linking outcome in patients with progressive keratoconus

Biomed Res Int. 2015:2015:325157. doi: 10.1155/2015/325157. Epub 2015 Jan 6.

Abstract

Purpose: To evaluate the long-term results of accelerated corneal cross-linking (CXL) in patients with progressive keratoconus.

Methods: Sixteen patients underwent accelerated CXL at 6 mW/cm(2) for 15 minutes in one eye. The follow-up visits were scheduled on 7 days, 14 days, and 3, 12, and 24 months after the treatment.

Results: There were no significant differences (P > 0.05) between preoperative and 2-year postoperative mean values, respectively, in terms of uncorrected visual acuity, best spectacle-corrected visual acuity, maximum keratometry K max⁡, minimum keratometry K min⁡, corneal astigmatism, and corneal eccentricity index. We noted a significant flattening of the cornea in 18.7% of patients with a higher preoperative K max⁡ value (>50 D) and its steepening in patients with a lower K max⁡ value (<50 D) (6.25%). There was no significant difference in the central corneal thickness and the apical corneal thickness preoperatively and 2 years postoperatively. The mean demarcation line depth was 282 ± 11 μm. Persistent corneal haze was noted in 25% of patients.

Conclusions: Accelerated CXL appears to be a relatively effective procedure for the treatment of keratoconus in 2-year follow-up.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cornea / drug effects
  • Cornea / pathology*
  • Corneal Pachymetry
  • Corneal Topography
  • Cross-Linking Reagents / pharmacology*
  • Disease Progression*
  • Female
  • Humans
  • Keratoconus / pathology*
  • Keratoconus / physiopathology
  • Keratoconus / surgery*
  • Male
  • Ophthalmologic Surgical Procedures / methods*
  • Treatment Outcome
  • Visual Acuity / drug effects

Substances

  • Cross-Linking Reagents